Cohort Event Monitoring of safety of COVID-19 vaccines in special populations (pregnant and lactating women, children and adolescents, immunocompromised, people with history of allergy, people with prior SARS-CoV-2 infection) (Covid-Vaccine-Monitor CVM)

First published 23/08/2021

Last updated 12/01/2026

EU PAS number:

EUPAS42504

Study

Finalised

Documents

Study protocol

Initial protocol

CVM_WP1_Protocol_v2.0_20210714_final

English (793.44 KB - PDF) View document

Updated protocol

CVM_WP1_Protocol_v2.1_20210729

First published: 22/02/2024

English (1.42 MB - PDF) View document

Study results

EUPAS42504-105818

English (567.7 KB - PDF) View document

Study report

Other information

Publications

Study publications

Secondary tabs